BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2002
View Archived Issues
Transgene's Ad-IFNgamma product candidate enters phase I trial for cutaneous lymphoma
Read More
FDA approves Pravachol 80 mg
Read More
Onyvax initiates phase II trial of Onyvax P in prostate cancer
Read More
First patients treated in phase II trial of PhotoPoint drug MV-9411 in psoriasis
Read More
Recurrence data from phase III trial of Polyphenon E show efficacy in genital warts
Read More
AIDS drug MDI-P shows no toxicity in preclinical tests
Read More
Neoprobe closes acquisition of Biosonix
Read More
CT-025 as an effective means of delivering calcitonin by oral administration
Read More
Japanese labs discontinue compound for perioperative hypertension
Read More
Siderophore-acylaminopenicillins highly active against resistant Gram-negative pathogens
Read More
Promising fluoroquinolones emerge from R&D at Indian pharmaceutical company
Read More
Preclinical data support further development of P-113D as CF therapy
Read More
deCODE Genetics to acquire MediChem Life Sciences
Read More
Solaraze now being marketed for actinic keratosis in U.S.
Read More
Medarex's tumor vaccine program to evaluate melanoma vaccines in conjunction with MDX-010
Read More
Sanofi-Synthelabo transfers Gabitril rights to Cephalon
Read More
First human trial yields positive data on L-dT, a potential new therapy for HBV
Read More
Epimmune and Rhein Biotech enter research agreement for vaccine development
Read More
Pilot study shows Symlin improves daily glucose profile in type 1 diabetes patients
Read More
Biovail files NDA for FlashDose version of zolpidem tartrate
Read More
Genta files IND for gallium nitrate in NHL
Read More
Abbott will manufacture oritavancin under new agreement
Read More
Ortho-McNeil claims series of PDE5 inhibitors and use in sexual dysfunction
Read More
Inhibitors of MMP enzymes described by Darwin Discovery
Read More
Pyrazole-based inhibitors of TNF-alpha signaling particularly useful in multiple sclerosis
Read More
Novel series of agents for influenza identified by Sankyo
Read More
Selective inhibitors of HSL described by Novo Nordisk team
Read More
Recent patents cover new beta3-adrenoceptor agonists designed at Asahi
Read More